from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0281/-

LFCtreatmentdescriptionclass of inhibitor

-0.644

Amikacinug/mL Amikacintranslation

-0.331

Cap5-10ug/mL Capreomycintranslation

-0.828

Rox10-50 ug/mL Roxithromycintranslation

0.625

SM2-5 ug/mL Streptomycintranslation

-2.014

Tet5-10 ug/mL Tetracyclinetranslation

0.012

Rif0.2-5ug/mL Rifampicintranscription

-0.419

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.043

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.832

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.009

CPZ10-50 ug/mL Chlorpromazinerespiration

0.447

Clofazimine10-13 ug/mL Clofaziminerespiration

0.266

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.307

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.536

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.684

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.415

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.201

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.228

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.418

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.136

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.651

KCN5-20 ug/mL Potassium cyaniderespiration

0.189

NaN30.2-2 mM Sodium aziderespiration

0.233

Nigericin50 uM Nigericinrespiration

-0.197

TRC10-150 ug/mL Triclosanrespiration

-0.410

TRZ10-25 ug/mL Thioridazinerespiration

3.402

Valinomycin0.5-10 uM Valinomycinrespiration

-0.795

ZnSO42 mM ZnSO4respiration

0.099

menadione6-10 ug/mL Menadionerespiration

0.228

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.061

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.012

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.578

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.413

NRP_1Non-replicating persistence stage 1dosRassociated

-0.552

Amp0.2mg/mL AmpicillincellWall

-0.245

Cephalexin20-100 ug/mL CephalexincellWall

0.565

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.073

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.053

EMB10-20 ug/mL EthambutolcellWall

0.086

Eta12-40 ug/mL EthionamidecellWall

0.017

INH0.2-0.4 ug/mL IsoniazidcellWall

0.095

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.554

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.094

BZA0.12 mg/mL BenzamidearomaticAmides

-0.162

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.232

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.173

H2O24 mM hydrogen peroxideDNAdamaging

1.217

Levo10 ug/mL LevofloxacinDNAdamaging

-0.604

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

4.826

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.964

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.180

UVUV-irradiationDNAdamaging

0.856

ARP41-4 ug/mL Antitubercular compound ARP4?

0.125

Antimycin12.5-50 ug/mL Antimycin A?

0.091

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.998

PA_110-50 ug/mL Antitubercular compound PA-1?

0.634

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.784

PA8240.2-2 ug/mL PA-824?

-2.147

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.246

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.065

Verapamil50 uM Verapamil?

0.213

mercaptoethanol2 mM 2-Mercaptoethanol?

0.339

methoxatin10-20 ug/mL Methoxatin?